Literature DB >> 7214747

Red cell membrane phospholipid abnormalities in the hemolytic uremic syndrome.

S O'Regan, R W Chesney, B S Kaplan, K N Drummond.   

Abstract

Eight patients with the hemolytic uremic syndrome had depression of percentage of red cell phosphatidyl ethanolamine content. Five patients also had subnormal plasma tocopherol levels. In addition all patients had significant increases in total plasma lipids which could contribute to peroxidative damage. The association of depressed red cell phosphatidyl ethanolamine and plasma tocopherol levels is suggestive of peroxidative damage, and may contribute to the hemolysis in this syndrome.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7214747

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  10 in total

1.  Escherichia coli O157:H7, other verotoxin-producing E coli and the hemolytic uremic syndrome in childhood.

Authors:  P C Rowe
Journal:  Can J Infect Dis       Date:  1995-03

Review 2.  Pathogenesis of the hemolytic uremic syndromes: current concepts.

Authors:  B S Kaplan; V V Vedaranayanan
Journal:  Indian J Pediatr       Date:  1988 Jul-Aug       Impact factor: 1.967

Review 3.  Reactive oxygen molecules, oxidant injury and renal disease.

Authors:  S P Andreoli
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

Review 4.  Hemolytic uremic syndrome.

Authors:  B R Nammalwar; N Balasubramanian; C Thangadurai; B R Santhanakrishnan
Journal:  Indian J Pediatr       Date:  1987 Sep-Oct       Impact factor: 1.967

5.  Cholestatic jaundice in the haemolytic-uraemic syndrome: a case report.

Authors:  G Jeffrey; C C Kibbler; R Baillod; K Farrington; M Y Morgan
Journal:  Gut       Date:  1985-03       Impact factor: 23.059

6.  Vitamin E treatment of haemolytic uraemic syndrome.

Authors:  H R Powell; D A McCredie; C M Taylor; J R Burke; R G Walker
Journal:  Arch Dis Child       Date:  1984-05       Impact factor: 3.791

7.  Further evidence of lipid peroxidation in post-enteropathic haemolytic-uraemic syndrome.

Authors:  R D Situnayake; B J Crump; D I Thurnham; C M Taylor
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

8.  Oxidative damage of red blood cells in haemolytic uraemic syndrome.

Authors:  S Túri; I Németh; I Vargha; B Matkovics
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

9.  The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome.

Authors:  M D Walters; I U Matthei; R Kay; M J Dillon; T M Barratt
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

10.  Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome.

Authors:  M Levin; K B Elkon; T J Nokes; A M Buckle; M J Dillon; R M Hardisty; T M Barratt
Journal:  Arch Dis Child       Date:  1983-09       Impact factor: 3.791

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.